welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Comparison of Nonampullary Duodenal Adenomas in Patients with Familial Adenomatous Polyposis Versus Patients with Sporadic Adenomas
source: Gastrointestinal Endoscopy
year: 2016
authors: Cassani LS, Lanke G, Chen HC, Wang X, Lynch P, Lee JH
summary/abstract:BACKGROUND AND AIMS:
Nonampullary duodenal adenomas are either sporadic or associated with a hereditary syndrome such as familial adenomatous polyposis (FAP). The aim of this study is to compare characteristics and outcomes of sporadic and FAP-associated duodenal adenomas.
METHODS:
We retrospectively collected clinical, endoscopic, and pathologic data in patients diagnosed with duodenal adenomas at our institution and included all available follow-up.
RESULTS:
Two hundred thirteen subjects were identified; 118 had FAP and 95 had sporadic adenomas. FAP subjects were more likely to have multifocal disease. Initial size was not significantly associated with dysplasia. Fourteen (12%) with FAP and 33 (35%) with sporadic adenomas underwent EMR. Among those subjects who did not undergo EMR or surgery, there was no difference between the FAP and sporadic groups with progression to new dysplasia or cancer. However, the FAP group was significantly more likely to have dysplasia at follow-up (P = .05). There was a significant difference in overall survival between the FAP and sporadic groups (log-rank test, P < .001). In the subgroup of patients aged 40 years old and older who did not undergo intervention, the FAP group had a shorter time to pathology progression compared with the similar sporadic subgroup. Range of time to progression to cancer was 3 to 161 months.
CONCLUSIONS:
FAP subjects were more likely to be younger and have multifocal disease. Progression of pathology was more likely in the older FAP group compared with the sporadic group. Time to progression to cancer was widely variable and, therefore, unpredictable.
organization: MD Anderson Cancer Center, Emory UniversityDOI: 10.1016/j.gie.2016.08.005
read more full text source
expertly curated content related to this topic
-
Desmoid Update – NIH clinical trial!https://www.youtube.com/watch?v=OE_GSI8A...
-
Desmoid Tumour in Familial Adenomatous Polyposis Patients: Responses to TreatmentsNo guidelines for desmoid tumors (DT) ma...
-
Cancer Support CommunityAnyone impacted by a diagnosis of cancer...
-
Familial Adenomatous Polyposis-Associated Papillary Thyroid CancerPapillary thyroid carcinoma (PTC) associ...
-
Familial Adenomatous Polyposis and HypertensionIn October, 2008, a 36-year-old man was ...
-
Could APC Gene Screening be Useful in Children with Hepatoblastoma? Early Onset of Adenocarcinoma in a Child with Fa...Familial adenomatous polyposis is an inh...
-
Hereditary Colorectal Cancer Syndromes: American Society of Clinical Oncology Clinical Practice Guideline Endorsemen...PURPOSE: To provide recommendations on ...